Cargando…
Combining clinical and biofluid markers for early Parkinson's disease detection
Accurate early diagnosis of Parkinson's disease is essential. Using data available from the Parkinson's Progression Markers Initiative study, we identified a multivariate logistic regression model including cerebrospinal fluid α‐synuclein, olfactory function, age, and gender that achieved...
Autores principales: | Yu, Zhenwei, Stewart, Tessandra, Aasly, Jan, Shi, Min, Zhang, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5771326/ https://www.ncbi.nlm.nih.gov/pubmed/29376098 http://dx.doi.org/10.1002/acn3.509 |
Ejemplares similares
-
Temporal trajectory of biofluid markers in Parkinson’s disease
por: Baek, Min Seok, et al.
Publicado: (2021) -
Evaluation of peripherin in biofluids of patients with motor neuron diseases
por: Sabbatini, Daniele, et al.
Publicado: (2021) -
Clinical and Imaging Markers of Prodromal Parkinson's Disease
por: Hustad, Eldbjørg, et al.
Publicado: (2020) -
Biofluid Markers for Prodromal Parkinson's Disease: Evidence From a Catecholaminergic Perspective
por: Vermeiren, Yannick, et al.
Publicado: (2020) -
Status of Current Biofluid Biomarkers in Parkinson's Disease
por: Mollenhauer, Brit
Publicado: (2023)